Treatment of recalcitrant warts with Bacillus Calmette-Guérin: A promising new approach

Dermatologic Therapy

Volumn 26, Issue 6, 2013, Pages 481-485

  Nofal, Ahmad ^a   Yosef, Ayman ^a   Salah, Eman ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

BCG vaccine; intralesional immunotherapy; recalcitrant warts

Indexed keywords

BCG VACCINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BCG VACCINATION; CASE REPORT; DRUG FEVER; FLU LIKE SYNDROME; FOLLOW UP; HUMAN; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; INJECTION SITE ULCER; LYMPHADENOPATHY; MALE; PUSTULE; RECALCITRANT WART; SIDE EFFECT; SKIN EXAMINATION; SKIN INDURATION; SKIN PIGMENTATION; SKIN ULCER; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULIN TEST; VERRUCA VULGARIS;

BCG VACCINE; INTRALESIONAL IMMUNOTHERAPY; RECALCITRANT WARTS;

BCG VACCINE; FOOT DISEASES; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; REMISSION INDUCTION; WARTS;

EID: 84890075731     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12019     Document Type: Article

References (25)

1. Leung L,. Recalcitrant nongenital warts. Aust Fam Physician 2011: 40: 40-42.
2. Micali G, Dall'Oglio F, Nasca MR, Tedeschi A,. Management of cutaneous warts: an evidence-based approach. Am J Clin Dermatol 2004: 5: 311-317.
3. Goihman-Yahr M, Goldblum OM,. Immunotherapy and warts: a point of view. Clin Dermatol 2008: 26: 223-225.
4. Nofal A, Nofal E,. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol 2010: 63: 1166-1170.
5. Huo W, Gao XH, Sun XP, et al. Local hyperthermia at 44 degrees C for the treatment of plantar warts: a randomized, patient-blinded, placebo-controlled trial. J Infect Dis 2010: 201: 1169-1172.
6. Tzellos TG, Sardeli C, Lallas A, Papazisis G, Chourdakis M, Kouvelas D,. Efficacy, safety and tolerability of green tea catechins in the treatment of external anogenital warts: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2011: 25: 345-353.
7. Tian YP, Yao L, Malla P, Song Y, Li SS,. Successful treatment of giant condyloma acuminatum with combination retinoid and interferon-γ therapy. Int J STD AIDS 2012: 23: 445-447.
8. Bacelieri R, Johnson SM,. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician 2005: 72: 647-652.
9. Maronn M, Salm C, Lyon V, Galbraith S,. One-year experience with Candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol 2008: 25: 189-192.
10. Johnson SM, Roberson PK, Horn TD,. Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol 2001: 137: 451-455.
11. Clifton MM, Johnson SM, Roberson PK, Kincannon J, Horn TD,. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr Dermatol 2003: 20: 268-271.
12. Johnson SM, Horn TD,. Intralesional immunotherapy for warts using a combination of skin test antigens: a safe and effective therapy. J Drugs Dermatol 2004: 3: 263-265.
13. Kus S, Ergun T, Gun D, Akin O,. Intralesional tuberculin for treatment of refractory warts. J Eur Acad Dermatol Venereol 2005: 19: 515-516.
14. Metawea B, El-Nashar AR, Kamel I, Kassem W, Shamloul R,. Application of viable bacille Calmette-Guérin topically as a potential therapeutic modality in condylomata acuminata: a placebo-controlled study. Urology 2005: 65: 247-250.
15. Sharquie KE, Al-Rawi JR, Al-Nuaimy AA, Radhy SH,. Bacille Calmette-Guerin immunotherapy of viral warts. Saudi Med J 2008: 29: 589-593.
16. Rivera A, Tyring SK,. Therapy of cutaneous human papillomavirus infections. Dermatol Ther 2004: 17: 441-448.
17. Malison MD, Salkin D,. Attempted BCG immunotherapy for condylomata acuminata. Br J Vener Dis 1981: 57: 148.
18. Gupta S, Malhotra AK, Verma KK, Sharma VK,. Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study. J Eur Acad Dermatol Venereol 2008: 22: 1089-1093.
19. Luo Y, Henning J, O'Donnell MA,. Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer. Clin Dev Immunol 2011: 2011: 728930.
20. Bohle A, Buttner H, Jocham D,. Primary treatment of condylomata acuminata with viable bacillus Calmette-Guerin. J Urol 2001: 165: 834-836.
21. Horn TD, Johnson SM, Helm RM, Roberson PK,. Intralesional immunotherapy of warts with mumps, Candida and trichophyton skin test antigens: a single-blinded, randomized and controlled trial. Arch Dermatol 2005: 141: 589-594.
22. Bohle A, Doehn C, Kausch I, Jocham D,. Treatment of recurrent penile condylomata acuminata with external application of bacillus Calmette-Guerin. J Urol 1998: 160: 394-396.
23. Yu X, Ye Z, Yang W, Deng R,. Efficacy of local injection of bacillus Calmette-Guerin polysaccharide nucleic acid following CO2 laser resection on condyloma acuminatum. Zhonghua Nan Ke Xue 2004: 10: 117-118.
24. Yuan SY, Lun X, Liu DS, Qin Z, Chen WT,. Acupoint-injection of BCG polysaccharide nuclear acid for treatment of condyloma acuminatum and its immunoregulatory action on the patient. Zhongguo Zhen Jiu. 2007: 27: 407-411.
25. Goldstone SE, Palefsky JM, Winnett MT, Neefe JR,. Activity of HspE7, a novel immunotherapy, in patients with anogenital warts. Dis Colon Rectum 2001: 45: 502-507.